kidney disease
Conditions
Interventions
Intervention Group:transversus abdominis plane block with ropivacaine
Control Group:transversus abdominis plane block with normal saline
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged between 18 and 70 years who were scheduled to undergo elective laparoscopic /robot-assisted partial or radical nephrectomy; 2. Patients who assigned the informed consent document before surgery.;Inclusion criteria: 1. Patients aged between 18 and 70 years who were scheduled to undergo elective laparoscopic /robot-assisted partial or radical nephrectomy; 2. Patients who assigned the informed consent document before surgery.;Inclusion criteria: 1. Patients aged between 18 and 70 years who were scheduled to undergo elective laparoscopic /robot-assisted partial or radical nephrectomy; 2. Patients who assigned the informed consent document before surgery.;Inclusion criteria: 1. Patients aged between 18 and 70 years who were scheduled to undergo elective laparoscopic /robot-assisted partial or radical nephrectomy; 2. Patients who assigned the informed consent document before surgery.;Inclusion criteria: 1. Patients aged between 18 and 70 years who were scheduled to undergo elective laparoscopic /robot-assisted partial or radical nephrectomy; 2. Patients who assigned the informed consent document before surgery.
Exclusion criteria
Exclusion criteria: 1. Refuse to participate; 2. Chronic opium-addiction and take other kind of analgesic drugs beyond 3 months; 3. Unable to communicate due to severe dementia, language barrier or end-stage disease; 4. Allergic to local anesthetics; 5. Nerve block contraindication such as infection in the puncture site or severe coagulation dysfunction; 6. Any other conditions that are considered unsuitable for study participation.;Exclusion criteria: 1. Refuse to participate; 2. Chronic opium-addiction and take other kind of analgesic drugs beyond 3 months; 3. Unable to communicate due to severe dementia, language barrier or end-stage disease; 4. Allergic to local anesthetics; 5. Nerve block contraindication such as infection in the puncture site or severe coagulation dysfunction; 6. Any other conditions that are considered unsuitable for study participation.;Exclusion criteria: 1. Refuse to participate; 2. Chronic opium-addiction and take other kind of analgesic drugs beyond 3 months; 3. Unable to communicate due to severe dementia, language barrier or end-stage disease; 4. Allergic to local anesthetics; 5. Nerve block contraindication such as infection in the puncture site or severe coagulation dysfunction; 6. Any other conditions that are considered unsuitable for study participation.;Exclusion criteria: 1. Refuse to participate; 2. Chronic opium-addiction and take other kind of analgesic drugs beyond 3 months; 3. Unable to communicate due to severe dementia, language barrier or end-stage disease; 4. Allergic to local anesthetics; 5. Nerve block contraindication such as infection in the puncture site or severe coagulation dysfunction; 6. Any other conditions that are considered unsuitable for study participation.;Exclusion criteria: 1. Refuse to participate; 2. Chronic opium-addiction and take other kind of analgesic drugs beyond 3 months; 3. Unable to communicate due to severe dementia, language barrier or end-stage disease; 4. Allergic to local anesthetics; 5. Nerve block contraindication such as infection in the puncture site or severe coagulation dysfunction; 6. Any other conditions that are considered unsuitable for study participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the amount of opioid drugs used during the anesthesia period;the amount of opioid drugs used in the first 24 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS pain score;the incidence of postoperative nausea and vomiting;the time interval for the first bolus opioid after surgery;the length of stay in hospital after surgery; | — |
Countries
China
Contacts
Public ContactZengmao Lin;Zengmao Lin;Zengmao Lin;Zengmao Lin;Zengmao Lin ;;;;
Peking University First Hospital;Peking University First Hospital;Peking University First Hospital;Peking University First Hospital;Peking University First Hospital
Outcome results
None listed